Telix Pharmaceuticals
TLX.AX
$9.69
Share price
0.89%
Change (1 day)
40.03%
Change (1 year)
Categories
Operating Margin for Telix Pharmaceuticals (TLX.AX)
Operating Margin at the end of 2022: -63.23%
According to Telix Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -63.22%. At the end of 2022 the company had an Operating Margin of -63.23%.
Operating Margin history for Telix Pharmaceuticals from 2018 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -63.23% | -96.15% |
| 2021 | -1,642.81% | 60.39% |
| 2020 | -1,024.25% | 14.69% |
| 2019 | -893.03% | -88.91% |
| 2018 | -8,052.54% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.